Similarly, in a rat model of cirrhosis, treatment with IGF-1 was demonstrated to increase mitochondrial membrane potential and ATP synthase activity and to reduce intramitochondrial free radical production, caspase activation, and apoptosis (14). The gene discussed is IGF1; the disease is Cirrhosis.